This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Additionally, evaluating the firm's approach to communication and collaboration is crucial. Novotech Novotech is a global full-service clinical ContractResearchOrganization (CRO) specializing in drug development consulting for biotech and pharmaceutical companies. What drug development consulting firm will you choose?
27 th August 2024 – Frost & Sullivan recently assessed the biotech contractresearchorganization (CRO) industry and, based on its results, recognizes Avance Clinical with the 2024 Global Customer Value Leadership Award. SAN ANTONIO, TX. –
This is fueling the growing demand for outsourcing, with contractresearchorganizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%.
CSSi LifeSciences CSSi LifeSciences is a global, innovative ContractResearchOrganization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. Collaborative Approach: Choose a firm that values collaboration and open communication.
It also facilitates collaboration between traditionally separate industries, creating new opportunities for growth and innovation. Contractresearchorganizations (CROs) and pharmaceutical companies are using AI to refine their go-to-market strategies, improve patient recruitment, and enhance retention for decentralized trials.
Growing demand for outsourcing, with contractresearchorganizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. Top 10 pharma companies contribute only 4-5% to R&D pipeline; top 25 contribute less than 10%.
April 25, 2023 – Frost & Sullivan researched the contractresearchorganizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. SAN ANTONIO, TX.
LifeSphere supports hundreds of global life sciences companies to accelerate development, maintain compliance, and streamline collaboration between cross-functional teams. A data-first platform, LifeSphere® centralizes content for unified reporting and reference data management.
Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem. Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape.
Innovating for Growth: The Future of Biotech CROs The biotech ContractResearchOrganization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. What are the top three trends you see driving change? Yvonne Lungershausen: Thank you, Unmesh.
As pharmaceutical innovation continues to reshape the industry, key focuses at DCAT Week 2025 included manufacturing capacity expansion, supply chain resilience, digital transformation, and strategic collaborations. trillion in 2024, is expected to grow at a 7% CAGR through 2030.
13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contractresearchorganization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.
CSSi LifeSciences CSSi LifeSciences is a global, innovative ContractResearchOrganization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. Collaborative Approach: Choose a firm that values collaboration and open communication.
San Antonio, TX — 14 th October 2024 — Frost & Sullivan recently conducted an in-depth analysis of the biotech contractresearchorganization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content